of Regulation S-K. PDL Biopharma agrees to furnish supplementally a copy of any omitted schedule to the SEC upon its request. [***] Certain information in this document has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested with respect to the omitted portions Exhibit L Press Release
of Regulation S-K. Autobytel Inc. will furnish supplementally a copy of any omitted schedule or exhibit to the Securities and Exchange Commission upon request; provided, however, that Autobytel Inc. may request confidential treatment pursuant to Rule 24b-2 of the Securities Exchange Act of 1934, as amended, for any schedule or exhibit so furnished.
of Regulation S-K. The Registrant hereby agrees to furnish supplementally a copy of any omitted schedule to the Securities and Exchange Commission upon request.
of Regulation S-K. The Registrant agrees to furnish to the Securities and Exchange Commission, to supplement and upon request, a copy of any of the following omitted Exhibits and Schedules. Capitalized terms used but not otherwise defined herein shall have the meaning ascribed to such terms by the foregoing Second Amendment Agreement.
of Regulation S-K. The Registrant hereby agrees to furnish supplementally a copy of this omitted exhibit to the Securities and Exchange Commission upon request. PERSONS TO SIGN RELEASE
of Regulation S-K. The Registrant hereby undertakes to furnish such annexes and exhibits to the Commission supplementally upon request.) ANNEXES Annex A — Definitions Annex B — Transferred Subsidiaries Annex C — Selling Affiliates Annex 1.01(a) — Seller’s Knowledge Annex 1.01(c)(iv) — Permitted Encumbrances Annex 2.01(c)(i) — Other Excluded Assets Annex 2.01(c)(xvi) — Excluded Contracts Annex 2.01(d) — Excluded Assets of Transferred Subsidiaries Annex 2.02(b)(i) — Excluded Liabilities Annex 2.02(b)(ii) — Excluded Proceedings Annex 2.02(b)(iv) — Excluded Environmental Liabilities Annex 2.07 — Closing Statement Principles and Illustrative Closing Statement Annex 2.09 — Allocation of the Finally Determined Purchase Price Annex 4.03 — Statement of Net Asset Rules Annex 4.11 — Product Marks and Products Under Registration Annex 4.14 — Excluded Employees Annex 6.01 — Conduct of Business Annex 6.05 — Transfer of Product Approvals and Product Applications Annex 6.06 — Transfer of Asset Transferred Real Property Annex 6.08(e) — International Assignees Annex 6.08(k) — Group Retirement Benefit Arrangements Annex 6.08(l) — Valuation of net liabilities for post-employment benefits Annex 6.10 — Termination of Affiliate Contracts Annex 6.11 — Third Party Assurances Annex 6.14 — Counterparty Consents Annex 10.02(a)(iii) — Excluded Liabilities of Transferred Subsidiaries EXHIBITS Exhibit 2.05(b)(iii) — Form of Purchaser Assignment and Assumption Agreement Exhibit 6.12(a) — Terms of Transition Services Agreement Exhibit 6.12(b) — Terms of Manufacturing and Supply Agreement Exhibit 6.12(c) — Form of Technology License Agreement Exhibit 6.12(f) — Form of IP Assignment Agreement STOCK AND ASSET PURCHASE AGREEMENT THIS STOCK AND ASSET PURCHASE AGREEMENT (as it may be amended or supplemented from time to time in accordance with the terms hereof, this Agreement), dated as of April 22, 2014, is entered into by and between Novartis AG, a company incorporated under the laws of Switzerland (the Seller), and Xxx Xxxxx and Company, a corporation organized under the laws of Indiana (the Purchaser; each of the Purchaser and the Seller is a Party and together are the Parties).
of Regulation S-K. The Depositor shall provide its signature or power of attorney to the Trustee by electronic or fax transmission (with hard copy to follow by overnight mail) no later than noon (New York City time) on the Business Day prior to the 15th calendar day following the related Distribution Date for Form 10-D, and not later than the end of business on the 3rd Business Day after the Reportable Event for Form 8-K (provided, that in each case the Trustee shall not file the related form until the Depositor has given its approval thereof). If a Form 8-K or Form 10-D cannot be filed on time or if a previously filed Form 8-K or Form 10-D needs to be amended, the Trustee will follow the procedures set forth in this Article XIII. The signing party at the Depositor can be contacted at Morgan Stanley Capital I Inc., 1585 Broadway, New York, New York 10030, Xxxexxxxx: Warren Friend, wixx x xxxx xx Xxxxxxx Xxxxxx xxx Xxxxxxxe Wilke, Esq. xxx xhe signing party at the Xxxxxxx, xx xxplicaxxx, xxx xx xxntacted at U.S. Bank National Association at its Corporate Trust Office.
of Regulation S-K. Where a registrant is party to an oral contract that would be required to be filed as an exhibit pursuant to Item 601(b)(10) if it were written, the registrant should provide a written description of the contract similar to that required for oral contracts or arrangements pursuant to Item 601(b)(10)(iii).
of Regulation S-K. The schedules include a list of purchased assets and contracts, intellectual property, customers, consents, licenses and other information. A copy of any omitted schedule and/or exhibit will be furnished to the Securities and Exchange Commission upon request.
of Regulation S-K. The Company will furnish the omitted schedules to the U.S. Securities and Exchange Commission upon request.
